Heart failure guidelines and prescribing in primary care across Europe

BMC Health Services Research

Volumn 5, Issue , 2005, Pages

  Sturm, Heidrun B ^a   Van Gilst, Wiek H ^a   Swedberg, Karl ^b   Hobbs, F D Richard ^c   Haaijer Ruskamp, Flora M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SPIRONOLACTONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLYCOSIDE; NITRIC ACID DERIVATIVE; VASODILATOR AGENT;

ARTICLE; CARDIOLOGY; EUROPE; HEALTH CARE ORGANIZATION; HEART FAILURE; HUMAN; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; CLASSIFICATION; COMPARATIVE STUDY; PRIMARY HEALTH CARE; STANDARDS;

ADRENERGIC BETA-AGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; CARDIOLOGY; DIURETICS; DOPAMINE AGONISTS; DRUG PRESCRIPTIONS; EUROPE; GLYCOSIDES; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; NITRATES; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; SPIRONOLACTONE; VASODILATOR AGENTS;

EID: 25644431899     PISSN: 14726963     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-5-57     Document Type: Article

References (24)

1. Cleland JG, Khand A, Clark A: The heart failure epidemic: exactly how big is it? Eur Heart J 2001, 22:623-626.
2. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J: The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003, 24:464-474.
3. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J: Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002, 360:1631-1639.
4. Bellotti P, Badano LP, Acquarone N, Griffo R, Lo PG, Maggioni AP, Mattiauda C, Menardo G, Mombelloni P: Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure; the OSCUR study. Oucome dello Scompenso Cardiaco in relazione all'Utilizzo delle Risore. Eur Heart J 2001, 22:596-604.
5. Grimshaw GM, Khunti K, Baker R: Diagnosis of heart failure in primary care: an assessment of international guidelines. Br J Gen Pract 2001, 51:384-386.
6. Kulig M, Erika S, Norbert WS: Comparing methodological quality and consistency of international guidelines for the management of patients with chronic heart failure. Eur J Heart Fail 2003, 5:327-335.
7. Burgers JS, Bailey JV, Klazinga NS, Van Der Bij AK, Grol R, Feder G: Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002, 25:1933-1939.
8. Iqbal A, Schloss S, George D, Isonaka S: Worldwide guidelines for chronic obstructive pulmonary disease: A comparison of diagnosis and treatment recommendations. Respirology 2002, 7:233-239.
9. The treatment of heart failure. The Task Force on Heart Failure of the European Society of Cardiology. Eur Heart J 1997, 18:736-753.
10. Grilli R, Magrini N, Penna A, Mura G, Liberati A: Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000, 355:103-106.
11. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709-717.
12. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation 1994, 90:1765-1773.
13. Burgers JS, Grol RPTM, Zaat JOM, Spies TH, Van Der Bij AK, Mokkink HGA: Characteristics of effective clinical guidelines for general practice. British Journal of General Practice 2003, 53:15-19.
14. Remme WJ: Towards the better treatment of heart failure. Eur Heart J 1998, 19 Suppl L:L36-L42.
15. Cline CM, Boman K, Holst M, Erhardt LR, Failure fS SS: The management of heart failure in Sweden. Eur J Heart Fail 2002, 4:373-376.
16. Komajda M, Bouhour JB, Amouyel P, Delahaye F, Vicaut E, Croce I, Rougemond E, Vuittenez F, Leutenegger E: Ambulatory heart failure management in private practice in France. Eur J Heart Fail 2001, 3:503-507.
17. McKee SP, Leslie SJ, LeMaitre JP, Webb DJ, Denvir MA: Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians. Eur J Heart Fail 2003, 5:549-555.
18. Rutten FH, Grobbee DE, Hoes AW: Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003, 5:337-344.
19. Fuat A, Hungin AP, Murphy JJ: Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003, 326:196.
20. Khunti K, Hearnshaw H, Baker R, Grimshaw G: Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 2002, 4:771-777.
21. Cluzeau F, Burgers J, Brouwers M, Grol R, Makela M, Littlejohns P, Grimshaw J, Hunt C: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality & Safety in Health Care 2003, 12:18-23.
22. Adams KF: Translating heart failure guidelines into clinical practice: clinical science and the art of medicine. Curr Cardiol Rep 2001, 3:130-135.
23. Wensing M, van der WT, Grol R: Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract 1998, 48:991-997.
24. van Veldhuisen DJ, Charlesworth A, Crijns HJ, Lie KI, Hampton JR: Differences in drug treatment of chronic heart failure between European countries. Eur Heart J 1999, 20:666-672.